228 related articles for article (PubMed ID: 28859704)
1. An update on the epidemiology of aspirin-exacerbated respiratory disease.
White AA
Am J Rhinol Allergy; 2017 Sep; 31(5):299-301. PubMed ID: 28859704
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
Haque R; White AA; Jackson DJ; Hopkins C
J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.
Stevens WW; Peters AT; Hirsch AG; Nordberg CM; Schwartz BS; Mercer DG; Mahdavinia M; Grammer LC; Hulse KE; Kern RC; Avila P; Schleimer RP
J Allergy Clin Immunol Pract; 2017; 5(4):1061-1070.e3. PubMed ID: 28286156
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
Rajan JP; Wineinger NE; Stevenson DD; White AA
J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
[TBL] [Abstract][Full Text] [Related]
7. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin G4 sinusitis in association with aspirin-exacerbated respiratory disease.
Johal K; Welch K; Peters A
Am J Rhinol Allergy; 2017 Sep; 31(5):302-304. PubMed ID: 28859705
[TBL] [Abstract][Full Text] [Related]
9. Aspirin-exacerbated respiratory disease: longitudinal assessment of a large cohort and implications of diagnostic delay.
Kshirsagar RS; Chou DW; Wei J; Liang J
Int Forum Allergy Rhinol; 2020 Apr; 10(4):465-473. PubMed ID: 32104978
[TBL] [Abstract][Full Text] [Related]
10. Comorbid diseases in aspirin-exacerbated respiratory disease, and asthma.
Erdogan T; Karakaya G; Kalyoncu AF
Allergol Immunopathol (Madr); 2015; 43(5):442-8. PubMed ID: 25547458
[TBL] [Abstract][Full Text] [Related]
11. Inheritance of NSAID-Exacerbated Respiratory Disease.
Suikkila A; Lyly A; Hafrén L; Saarinen R; Klockars T
Otolaryngol Head Neck Surg; 2023 Mar; 168(3):540-543. PubMed ID: 35639475
[TBL] [Abstract][Full Text] [Related]
12. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
[TBL] [Abstract][Full Text] [Related]
13. Aspirin exacerbated respiratory disease: Current topics and trends.
Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
[TBL] [Abstract][Full Text] [Related]
14. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
Woessner KM; Simon RA; Stevenson DD
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):339-44. PubMed ID: 15521369
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of aspirin hypersensitivity in patients with nasal polyposis and contributing factors.
Bavbek S; Dursun B; Dursun E; Korkmaz H; Sertkaya Karasoy D
Am J Rhinol Allergy; 2011; 25(6):411-5. PubMed ID: 22185746
[TBL] [Abstract][Full Text] [Related]
16. Current complications and treatment of aspirin-exacerbated respiratory disease.
Cook KA; Stevenson DD
Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
[TBL] [Abstract][Full Text] [Related]
17. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
O'Brien EK; Jerschow E; Divekar RD
Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
[TBL] [Abstract][Full Text] [Related]
18. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
[TBL] [Abstract][Full Text] [Related]
19. Aspirin-Exacerbated Respiratory Disease.
Walgama ES; Hwang PH
Otolaryngol Clin North Am; 2017 Feb; 50(1):83-94. PubMed ID: 27888917
[TBL] [Abstract][Full Text] [Related]
20. Association Between Aspirin-Exacerbated Respiratory Disease and Atherosclerotic Cardiovascular Disease: A Retrospective Review of US Claims Data.
Adame MJ; Raji M; Shan Y; Zhang Y; Kuo YF; Tripple JW
J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3445-3453.e6. PubMed ID: 37468040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
